.Pharmacolibrary.Drugs.ATC.L.L03AA19

Information

name:Eflapegrastim
ATC code:L03AA19
route:subcutaneous
compartments:2
dosage:13.2mg
volume of distribution:0.11L
clearance:0.0272L/h/kg
other parameters in model implementation

Eflapegrastim is a long-acting, recombinant human granulocyte colony-stimulating factor (G-CSF) analog, conjugated to a human IgG4 Fc fragment via a polyethylene glycol linker. It is used for the reduction in the duration of severe neutropenia in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. It is approved for use in the United States.

Pharmacokinetics

Population pharmacokinetics in adult cancer patients; healthy volunteers and patients with breast cancer following subcutaneous administration.

References

    Revisions


    Generated at 2025-08-11T18:21:04Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos